Published on in Vol 21, No 10 (2019): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/15814, first published .
Estimating the Impact of Novel Digital Therapeutics in Type 2 Diabetes and Hypertension: Health Economic Analysis

Estimating the Impact of Novel Digital Therapeutics in Type 2 Diabetes and Hypertension: Health Economic Analysis

Estimating the Impact of Novel Digital Therapeutics in Type 2 Diabetes and Hypertension: Health Economic Analysis

Journals

  1. Wechkunanukul K, Parajuli D, Hamiduzzaman M. Utilising digital health to improve medication-related quality of care for hypertensive patients: An integrative literature review. World Journal of Clinical Cases 2020;8(11):2266 View
  2. Wolff J, Pauling J, Keck A, Baumbach J. Systematic Review of Economic Impact Studies of Artificial Intelligence in Health Care. Journal of Medical Internet Research 2020;22(2):e16866 View
  3. Kim H. Apprehensions about Excessive Belief in Digital Therapeutics: Points of Concern Excluding Merits. Journal of Korean Medical Science 2020;35(45) View
  4. Padwal R, Wood P. Digital Health Approaches for the Assessment and Optimisation of Hypertension Care Provision. Canadian Journal of Cardiology 2021;37(5):711 View
  5. Bulaj G, Clark J, Ebrahimi M, Bald E. From Precision Metapharmacology to Patient Empowerment: Delivery of Self-Care Practices for Epilepsy, Pain, Depression and Cancer Using Digital Health Technologies. Frontiers in Pharmacology 2021;12 View
  6. Verma R, Bhardwaj S, Lathia T, Kalra S, Ranadive R, Tanna S, Padsalge M, Juneja A, Samundra K, Thakkar P, Jain V, Kini V, Kothari S, Guntur S, Joshi S, Singal A. Personalized glycemic response led digital therapeutics program improves time in range in a period of 14 days. International Journal of Diabetes in Developing Countries 2023;43(3):425 View
  7. Dwibedi C, Abrahamsson B, Rosengren A. Effect of Digital Lifestyle Management on Metabolic Control and Quality of Life in Patients with Well-Controlled Type 2 Diabetes. Diabetes Therapy 2022;13(3):423 View
  8. Dwibedi C, Mellergård E, Gyllensten A, Nilsson K, Axelsson A, Bäckman M, Sahlgren M, Friend S, Persson S, Franzén S, Abrahamsson B, Carlsson K, Rosengren A. Effect of self-managed lifestyle treatment on glycemic control in patients with type 2 diabetes. npj Digital Medicine 2022;5(1) View
  9. Kyaw T, Ng N, Theocharaki M, Wennberg P, Sahlen K. Cost-effectiveness of Digital Tools for Behavior Change Interventions Among People With Chronic Diseases: Systematic Review. Interactive Journal of Medical Research 2023;12:e42396 View
  10. Huh K, Oh J, Lee S, Yu K. Clinical Evaluation of Digital Therapeutics: Present and Future. Healthcare Informatics Research 2022;28(3):188 View
  11. Woo J, Kim E, Kim S. The current status of breakthrough devices designation in the United States and innovative medical devices designation in Korea for digital health software. Expert Review of Medical Devices 2022;19(3):213 View
  12. Nomura A, Tanigawa T, Kario K, Igarashi A. Cost-effectiveness of digital therapeutics for essential hypertension. Hypertension Research 2022;45(10):1538 View
  13. Sang-Yoon P. Teledentistry and Digital Therapeutics (DTx) for dentistry. Journal of Clinical Advances in Dentistry 2022;6(1):028 View
  14. Caillat M, Degott J, Wuerzner A, Proençain M, Bonnier G, Knebel J, Stoll C, Christen U, Durgnat V, Hofmann G, Burnier M, Wuerzner G, Schoettker P. Accuracy of blood pressure measurement across BMI categories using the OptiBP™ mobile application. Blood Pressure 2022;31(1):288 View
  15. Chua V, Koh J, Koh C, Tyagi S. The Willingness to Pay for Telemedicine Among Patients With Chronic Diseases: Systematic Review. Journal of Medical Internet Research 2022;24(4):e33372 View
  16. Zhang X, Luo Z, Yang M, Huang W, Yu P. Efficacy and safety of digital therapeutics‐based cardiac rehabilitation in heart failure patients: a systematic review. ESC Heart Failure 2022;9(6):3751 View
  17. Nakagami H. New wave of digital hypertension management for clinical applications. Hypertension Research 2022;45(10):1549 View
  18. Ben-Assuli O. Measuring the cost-effectiveness of using telehealth for diabetes management: A narrative review of methods and findings. International Journal of Medical Informatics 2022;163:104764 View
  19. Phan P, Mitragotri S, Zhao Z. Digital therapeutics in the clinic. Bioengineering & Translational Medicine 2023;8(4) View
  20. Gellert G, Rasławska-Socha J, Marcjasz N, Price T, Kuszczyński K, Młodawska A, Jędruch A, Orzechowski P. How Virtual Triage Can Improve Patient Experience and Satisfaction: A Narrative Review and Look Forward. Telemedicine Reports 2023;4(1):292 View
  21. Kumar D, Ingole A, Choudhari S. Towards Ideal Health Ecosystem With Artificial Intelligence-Driven Medical Services in India: An Overview. Cureus 2023 View
  22. Sapanel Y, Tadeo X, Brenna C, Remus A, Koerber F, Cloutier L, Tremblay G, Blasiak A, Hardesty C, Yoong J, Ho D. Economic Evaluation Associated With Clinical-Grade Mobile App–Based Digital Therapeutic Interventions: Systematic Review. Journal of Medical Internet Research 2023;25:e47094 View
  23. Tornvall I, Kenny D, Wubishet B, Russell A, Menon A, Comans T. Economic Evaluations of mHealth Interventions for the Management of Type 2 Diabetes: A Scoping Review. Journal of Diabetes Science and Technology 2023 View
  24. Davison N, Guthrie N, Medland S, Lupinacci P, Nordyke R, Berman M. Cost-Effectiveness Analysis of a Prescription Digital Therapeutic in Type 2 Diabetes. Advances in Therapy 2024;41(2):806 View

Books/Policy Documents

  1. Hong N, Park Y, You S, Rhee Y. Artificial Intelligence in Medicine. View
  2. Hong N, Park Y, You S, Rhee Y. Artificial Intelligence in Medicine. View